| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8580 | 
      | Human Intestinal Absorption | HIA+ | 0.9954 | 
      | Caco-2 Permeability | Caco2- | 0.5382 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7247 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8354 | 
                                                     | Non-inhibitor | 0.9774 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8936 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5584 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7236 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8641 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6917 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7801 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.6903 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8922 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.6608 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7197 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6947 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9592 | 
                                                                    | Non-inhibitor | 0.8488 | 
      | AMES Toxicity | Non AMES toxic | 0.7122 | 
      | Carcinogens | Non-carcinogens | 0.7435 | 
      | Fish Toxicity | Low FHMT | 0.5611 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.5612 | 
      | Honey Bee Toxicity | Low HBT | 0.7482 | 
      | Biodegradation | Not ready biodegradable | 0.9953 | 
      | Acute Oral Toxicity | III | 0.7177 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5413 |